Content Navigation
( All
None )
Target General Information |
Top |
Target ID |
T67619 |
Target Info
|
Target Name |
RAC-alpha serine/threonine-protein kinase (AKT1) |
Synonyms |
RAC-PK-alpha; RAC; Proto-oncogene c-Akt; Protein kinase B alpha; PKB alpha |
Target Type |
Successful Target |
Gene Name |
AKT1 |
Biochemical Class |
Kinase |
UniProt ID |
|
Patent(s) and the Corresponding Patented Drug(s) |
Top |
United States Patent and Trademark Office (USPTO) |
Patent ID |
US2015374692 |
Title |
Methods and Compositions Relating To The Treatment of Cancer. |
Representative Drug(s) |
D07QBF |
Drug Info
|
N.A. |
[1] |
References |
Top |
REF 1 |
Cancer stem cell (CSC) inhibitors: a review of recent patents (2012-2015).Expert Opin Ther Pat. 2017 Jul;27(7):753-761.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.